GYRE vs KMI · rev $53.5M vs P/E 24, rev $9.30B
Gyre Therapeutics Inc. (GYRE) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
GYRE currently screens at market cap $589.9M. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the GYRE and KMI stock pages for the full models.
Not investment advice.